| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/10/2006 | CN1768859A Method for assembling multi-biological functional factor on micro-particle surface based on aldehyde group |
| 05/10/2006 | CN1768855A Medicine for treating cervical carcinoma, its preparation process and application |
| 05/10/2006 | CN1255451C Preparation method of bioactive polylactic acid its product and application |
| 05/10/2006 | CN1255189C Preparation method of anticoagulant insoluble silk protein material |
| 05/10/2006 | CN1255185C Pharmaceutical dosage form of amorphous nelfinavir mesylate |
| 05/10/2006 | CN1255114C Amphotericin B aqueous composition |
| 05/10/2006 | CN1255105C Water soluble dressing materials of ziracitone and its salts and their preparation |
| 05/10/2006 | CN1255099C Method for encapsulating active substance |
| 05/09/2006 | US7041818 drug delivery system compound; carboxy(C1-4)alkyl-dextran polyalcohol modified with galactose or galactosamine and a residue of an antineoplastic or antiinflammatory agent bound to the carboxy(C1-4)alkyldextran polyalcohol; DX-8951 (Exatecan); liver cancer; improved tumor selectivity |
| 05/09/2006 | US7041787 Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases |
| 05/09/2006 | US7041786 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 05/09/2006 | US7041705 Injectable aqueous dispersions of propofol |
| 05/09/2006 | US7041651 Cellular uptake of bioactive agents |
| 05/09/2006 | US7041641 Kit comprising osteogenic protein, matrix derived from nonsynthetic, nonpolymeric material, and binding agent for induction of local bone or cartilage formation |
| 05/09/2006 | US7041640 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 05/09/2006 | US7041637 Echinocandin/carbohydrate complexes |
| 05/09/2006 | US7041504 Cancer cell-inhibiting culture medium produced by culturing restricted entrapped cancer cells |
| 05/09/2006 | US7041487 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 05/09/2006 | US7041478 Polypeptide for use in the treatment cancer, inflammation of autoimmune disorders |
| 05/09/2006 | US7041321 supercritically extracting an herb to obtain an oil extract and a residue;extracting the residue in a water/alcohol liquid mixture to obtain a post-supercritical hydroalcoholic extract; evaporating the water/alcohol liquid to form a powdered extract; mixing the powdered extract with the oil extract. |
| 05/09/2006 | US7041319 Fenofibrate pharmaceutical composition having high bioavailabilty |
| 05/09/2006 | US7041316 Stable oral pharmaceutical dosage forms |
| 05/09/2006 | US7041315 Pectin film compositions |
| 05/09/2006 | US7041313 e.g., pantoprazole; combination of one administration form that is the drug with a disintegrant and a sustained-release coating of a water-insoluble and plastic membrane with low swelling power in water and in which small soluble particles are embedded and other form is the drug with an enteric coating |
| 05/09/2006 | US7041312 Wound healing compositions and methods of use |
| 05/09/2006 | US7041311 Preparation for saliva flow |
| 05/09/2006 | US7041310 Drug supported by biodegradable polymer such as crosslinked hyaluronic acid |
| 05/09/2006 | US7041305 Stable water in oil aminophylline emulsions |
| 05/09/2006 | US7041294 Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects |
| 05/09/2006 | US7041241 Microspheres contain 5-fluorouracil coated with poly(d-l-lactic acid-co-glycolic acid); implanted in walls of operation site following exeresis of tumor, by intratissular injection |
| 05/09/2006 | US7040314 Aerosol generating devices and methods for generating aerosols suitable for forming propellant-free aerosols |
| 05/09/2006 | US7040311 Closure-cap and container as a two-chamber cartridge for nebulizers for producing aerosols and active substance formulations, suitable for storage |
| 05/09/2006 | CA2395653C New inhalable powder containing tiotropium |
| 05/09/2006 | CA2346662C Compositions containing diphosphonic acids |
| 05/09/2006 | CA2322501C Processes for the preparation of (r)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| 05/09/2006 | CA2246615C Biodegradable polymer networks for use in orthopedic and dental applications |
| 05/09/2006 | CA2175687C A bacterial nitroreductase gene-prodrug system |
| 05/09/2006 | CA2173506C Enteric granule-containing tablets |
| 05/04/2006 | WO2006047579A2 Vitamin e tpgs fluid concentrate comprising a low percentage of water |
| 05/04/2006 | WO2006047476A2 Therapeutic and delivery methods of prostaglandin ep4 agonists |
| 05/04/2006 | WO2006046933A1 Sedative and spasmolytic medicinal agent and method for the production thereof (variants) |
| 05/04/2006 | WO2006046623A1 Solid medicinal preparation improved in solubility and stability and process for producing the same |
| 05/04/2006 | WO2006046584A1 Remedy for visual cell injuries |
| 05/04/2006 | WO2006046560A1 Propiverine-containing oral particulate preparation and process for producing the same |
| 05/04/2006 | WO2006046080A2 Pegylated liposomal doxorubicin in combination with ecteinescidin 743 |
| 05/04/2006 | WO2006046079A1 Formulations comprising ecteinascidin and a disaccharide |
| 05/04/2006 | WO2006045238A1 Carbonized pollen and the use thereof for the preparation of anticancer drugs |
| 05/04/2006 | WO2006045152A1 Improved tabletting process |
| 05/04/2006 | WO2006038931A3 Odor-reducing quinone compounds |
| 05/04/2006 | WO2006031653A3 Humanized anti-5t4 antibodies and anti-5t4 antibody / calicheamicin conjugates |
| 05/04/2006 | WO2005110448A3 Nutritional composition for increasing creatine uptake in skeletal muscle |
| 05/04/2006 | WO2005106492A3 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 3 (ccr3) |
| 05/04/2006 | WO2005089809A3 Calicheamicin conjugation by antibody deglycosylation |
| 05/04/2006 | WO2005070901A3 Pyrimidyl phosphonate antiviral compounds and methods of use |
| 05/04/2006 | WO2005063169A3 Medical lipolysis of fat accumulations |
| 05/04/2006 | WO2005048944A3 Activatable photodynamic therapy agents |
| 05/04/2006 | WO2004030610A3 Compositions and methods for the intracellular delivery of antibodies |
| 05/04/2006 | WO2004004708A9 A pharmaceutical composition useful for treating chronic myeloid leukemia |
| 05/04/2006 | US20060094782 Compositions and dosage forms for enhanced absorption |
| 05/04/2006 | US20060094771 Carvedilol pharmasolve solvate |
| 05/04/2006 | US20060094698 Self-administered contraceptive injection of oily solution |
| 05/04/2006 | US20060094691 Inclusion complexes of rosiglitazone |
| 05/04/2006 | US20060094688 Histamine release inhibitor |
| 05/04/2006 | US20060094662 Pharmaceutical compositions for sustained drug delivery |
| 05/04/2006 | US20060094643 Compositions of hyaluronic acid and methods of use |
| 05/04/2006 | US20060094608 Mixture of polyol and insulation agent; heating upon exposure to moisture; for urogenital systems; dysmenorrhea |
| 05/04/2006 | US20060094032 iRNA agents targeting VEGF |
| 05/04/2006 | US20060094017 Immunogens for hiv vaccine |
| 05/04/2006 | US20060093671 Galantamine particles that may be in salt form and an excipient, coated by a release rate controlling membrane; alleviates Alzheimer's dementia and related dementias, when used in amounts insufficient to cause adverse effects |
| 05/04/2006 | US20060093670 Sustained-release composition process for producing the same and preparation thereof |
| 05/04/2006 | US20060093668 Melt granulated composition and modified release dosage form prepared from said composition |
| 05/04/2006 | US20060093667 Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency |
| 05/04/2006 | US20060093665 Method to improve surface properties of pharmaceutical tablets |
| 05/04/2006 | US20060093662 Liposomal camptothecins and uses thereof |
| 05/04/2006 | US20060093660 Compositions for treatment with glucagon-like peptide, and methods of making and using the same |
| 05/04/2006 | US20060093659 Hydroxide-releasing agents as skin permeation enhancers |
| 05/04/2006 | US20060093656 Warming patch |
| 05/04/2006 | US20060093651 Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials |
| 05/04/2006 | US20060093650 Methods for regulating weight and size of animals |
| 05/04/2006 | US20060093649 Food composition for recovery from fatigue |
| 05/04/2006 | US20060093648 Hydrogels for orthopedic repair |
| 05/04/2006 | US20060093636 Allantoin-containing skin cream |
| 05/04/2006 | US20060093630 Dye-free pharmaceutical suspensions and related methods |
| 05/04/2006 | US20060093627 Method of protecting chronic infections |
| 05/04/2006 | US20060093625 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and an orphanin polypeptide as a targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 05/04/2006 | US20060093613 Soluble T cell receptor |
| 05/04/2006 | US20060093611 from mammalian chondrocyte progenitor cells expressing mechanosensitive TWIK-related potassium (TREK) ion channels; biocompatability, in vitro |
| 05/04/2006 | US20060093598 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 05/04/2006 | US20060093576 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 05/04/2006 | US20060093553 Cd26-based therapies for cancers and immune disease |
| 05/04/2006 | US20060093551 Benzo[1,2,5]oxadiazoles and benzol[1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers |
| 05/04/2006 | US20060090766 Surface modified viscoelastics for ocular surgery |
| 05/04/2006 | DE19916208B4 Sonnenschutzmittel Sunscreens |
| 05/04/2006 | DE102004052533A1 Particles for use in diagnosis and therapy, especially for binding therapeutic agent for treating e.g. tumors and bacterial, rheumatic, neurologic and thrombotic diseases, have nanocrystalline magnetic core and envelope enclosing core |
| 05/04/2006 | DE102004051540A1 Preparation of powdered, water-soluble and/or water-swellable polymers, useful as thickeners for e.g. paper coating masses, comprises drying aqueous dispersions of ethylenically unsaturated anionic polymers in standard methods |
| 05/04/2006 | CA2586040A1 Sustained release of active molecules from polymers topically applied to skin or hair |
| 05/04/2006 | CA2585367A1 Therapeutic and delivery methods of prostaglandin ep4 agonists |
| 05/04/2006 | CA2583677A1 Tnf-like weak inducer of apoptosis (tweak) receptor binding domain |
| 05/03/2006 | EP1652539A1 Method of manufacturing a stent comprising an anti-angiogenic composition |
| 05/03/2006 | EP1652536A1 Wound treatment agent comprising a zeolite iod clathrat |